HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Hugh R Barrett Selected Research

Apolipoprotein B-48

3/2015Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
8/2014Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state.
1/2014Plasma apolipoprotein B-48 transport in obese men: a new tracer kinetic study in the postprandial state.
9/2008Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.
9/2005Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
3/2005Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.
2/2003Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Hugh R Barrett Research Topics

Disease

27Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021 - 01/2003
23Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 03/2002
21Insulin Resistance
10/2015 - 06/2002
18Dyslipidemias (Dyslipidemia)
11/2021 - 08/2002
15Abdominal Obesity
10/2015 - 05/2002
14Obesity
08/2016 - 05/2002
12Atherosclerosis
01/2018 - 01/2002
9Weight Loss (Weight Reduction)
11/2021 - 02/2003
9Hypertriglyceridemia
10/2016 - 06/2003
8Hyperlipidemias (Hyperlipidemia)
01/2017 - 09/2002
7Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2021 - 03/2002
7Hypobetalipoproteinemias (Hypobetalipoproteinemia)
06/2016 - 10/2004
6Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 09/2002
5Body Weight (Weight, Body)
08/2014 - 10/2009
5Overweight
05/2010 - 01/2003
4Type 2 Diabetes Mellitus (MODY)
12/2016 - 01/2002
4Hypercholesterolemia
10/2013 - 03/2002
3Coronary Disease (Coronary Heart Disease)
08/2014 - 02/2003
3Malaria
12/2007 - 07/2002
2Inflammation (Inflammations)
05/2016 - 05/2010
2Hepatocellular Carcinoma (Hepatoma)
02/2003 - 09/2002
1Carotid Stenosis (Carotid Artery Stenosis)
01/2018
1Fatty Liver
08/2017
1Hypertension (High Blood Pressure)
05/2016
1Carotid Artery Diseases
05/2016

Drug/Important Bio-Agent (IBA)

37Lipoproteins (Lipoprotein)IBA
11/2021 - 01/2002
34Apolipoproteins B (ApoB)IBA
12/2016 - 01/2002
29Triglycerides (Triacylglycerol)IBA
12/2016 - 01/2002
28ApolipoproteinsIBA
11/2021 - 01/2002
26Apolipoprotein B-100 (Apo B 100)IBA
11/2021 - 03/2002
19Apolipoprotein A-I (Apolipoprotein A1)IBA
11/2021 - 03/2003
16oxidized low density lipoproteinIBA
01/2018 - 09/2002
15Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2021 - 08/2002
13LipidsIBA
11/2021 - 06/2002
12HDL LipoproteinsIBA
11/2021 - 09/2004
12Apolipoprotein C-IIIIBA
10/2015 - 08/2002
12HDL CholesterolIBA
08/2014 - 06/2005
11LDL Lipoproteins (beta Lipoproteins)IBA
01/2019 - 03/2002
11CholesterolIBA
01/2018 - 03/2002
11Atorvastatin (Lipitor)FDA Link
11/2012 - 05/2002
10IsotopesIBA
11/2021 - 05/2002
10Fish OilsIBA
11/2021 - 06/2002
10LDL CholesterolIBA
01/2018 - 09/2002
9VLDL LipoproteinsIBA
11/2021 - 01/2003
8AdiponectinIBA
04/2013 - 09/2004
7Apolipoproteins AIBA
01/2019 - 07/2006
7Rosuvastatin Calcium (Crestor)FDA Link
01/2017 - 02/2008
7Fatty Acids (Saturated Fatty Acids)IBA
10/2016 - 02/2004
7Apolipoprotein B-48IBA
03/2015 - 02/2003
7Insulin (Novolin)FDA Link
05/2010 - 08/2002
6Lipoprotein(a)IBA
11/2021 - 12/2015
6LDL Receptors (LDL Receptor)IBA
01/2018 - 03/2002
6Fenofibrate (CiL)FDA LinkGeneric
11/2012 - 03/2003
6Apolipoprotein A-II (Apolipoprotein A2)IBA
05/2010 - 07/2006
5Fibric Acids (Fibrates)IBA
11/2021 - 02/2004
5ChylomicronsIBA
12/2016 - 02/2003
5Leucine (L-Leucine)FDA Link
10/2015 - 09/2002
4Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2004
4Niacin (Nicotinic Acid)FDA LinkGeneric
12/2016 - 09/2008
4Apolipoproteins E (ApoE)IBA
11/2012 - 01/2002
4Interleukin-6 (Interleukin 6)IBA
05/2010 - 06/2002
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
04/2010 - 02/2003
3Apoprotein(a) (Apolipoprotein (a))IBA
01/2019 - 01/2018
3naringeninIBA
10/2008 - 09/2002
3Cholesterol Ester Transfer ProteinsIBA
08/2008 - 02/2006
3Proteoglycans (Proteoglycan)IBA
11/2004 - 01/2002
3Chylomicron RemnantsIBA
02/2003 - 05/2002
2Proprotein Convertase 9IBA
05/2016 - 08/2006
2Palmitic Acid (Hexadecanoic Acid)IBA
06/2015 - 06/2013
2SphingolipidsIBA
06/2015 - 11/2014
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2011 - 05/2008
2C-Reactive ProteinIBA
05/2010 - 06/2002
2Vitamin A (Retinol)FDA LinkGeneric
05/2010 - 11/2007
2lathosterolIBA
05/2010 - 11/2009
2Antimalarials (Antimalarial Agents)IBA
12/2007 - 07/2002
2Phytosterols (Plant Sterols)IBA
01/2007 - 02/2003
2Phospholipid Transfer ProteinsIBA
09/2006 - 03/2006
2Nonesterified Fatty Acids (NEFA)IBA
08/2006 - 03/2004
2LigandsIBA
08/2006 - 10/2004
2LeptinIBA
03/2005 - 03/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005 - 03/2005
2EnzymesIBA
03/2005 - 02/2004
2ResistinIBA
03/2005 - 03/2005
2BiglycanIBA
11/2004 - 01/2002
2Biological ProductsIBA
09/2004 - 02/2004
2FlavonoidsIBA
02/2003 - 09/2002
1Protein Isoforms (Isoforms)IBA
01/2018
18- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
01/2018
1TamoxifenFDA LinkGeneric
08/2017
1low density lipoprotein inhibitorIBA
01/2017
1EstersIBA
10/2016
1Apolipoproteins C (ApoC)IBA
08/2016
1very low density lipoprotein triglycerideIBA
10/2015
1Glycerol (Glycerine)FDA LinkGeneric
10/2015
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2015
1CeramidesIBA
06/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2014

Therapy/Procedure

8Therapeutics
08/2017 - 07/2002
3Fat-Restricted Diet (Diet, Fat Restricted)
05/2010 - 11/2007
3Drug Therapy (Chemotherapy)
05/2010 - 02/2004